Unknown OBSERVATIONAL NCT03306823

Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation 1 (EAPCAAMHO1)

Multi-center, Single-blind, Prospective Cohort Study of Exploration of Anticoagulation Program in Cerebral Aneurysm and Arteriovenous Malformations With Hybrid Operation

Sponsor: Beijing Tiantan Hospital

Conditions Arteriovenous Malformations Cerebral Aneurysm

Updated 7 times since 2017 Last updated: Oct 10, 2017 Started: Sep 30, 2016 Primary completion: Sep 30, 2020 Completion: Aug 31, 2021

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Arteriovenous Malformations and Cerebral Aneurysm, this trial is ongoing. The trial is conducted by Beijing Tiantan Hospital and has accumulated 7 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting
Jun 2018 — Jan 2021 [monthly]

Recruiting

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Recruiting

Phase: NA → None
Oct 2017 — Apr 2018 [monthly]

Recruiting NA

First recorded

Sep 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Beijing Tiantan Hospital
First Affiliated Hospital of Fujian Medical University
Fujian Medical University Union Hospital
Kunming Medical University
Nanjing PLA General Hospital
Tang-Du Hospital

Data source: Beijing Tiantan Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Beijing, China